Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Beginning Cash Balance (2016 - 2025)

Historic Beginning Cash Balance for Niagen Bioscience (NAGE) over the last 5 years, with Q1 2018 value amounting to $45.4 million.

  • Niagen Bioscience's Beginning Cash Balance rose 266425.09% to $45.4 million in Q1 2018 from the same period last year, while for Mar 2018 it was $47.0 million, marking a year-over-year increase of 55397.07%. This contributed to the annual value of $420152.0 for FY2012, which is 8112.91% down from last year.
  • As of Q1 2018, Niagen Bioscience's Beginning Cash Balance stood at $45.4 million, which was up 266425.09% from $429.0 recorded in Q3 2017.
  • Niagen Bioscience's 5-year Beginning Cash Balance high stood at $45.4 million for Q1 2018, and its period low was $429.0 during Q3 2017.
  • In the last 3 years, Niagen Bioscience's Beginning Cash Balance had a median value of $3.6 million in 2016 and averaged $13.1 million.
  • Per our database at Business Quant, Niagen Bioscience's Beginning Cash Balance plummeted by 7041.27% in 2017 and then skyrocketed by 266425.09% in 2018.
  • Over the past 3 years, Niagen Bioscience's Beginning Cash Balance (Quarter) stood at $5.5 million in 2016, then tumbled by 99.99% to $429.0 in 2017, then skyrocketed by 10580086.48% to $45.4 million in 2018.
  • Its Beginning Cash Balance was $45.4 million in Q1 2018, compared to $429.0 in Q3 2017 and $1.6 million in Q2 2017.